Reportlinker Adds Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Summary
GlobalData's new report, "Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global cardiac markers market. The report provides market landscape, competitive landscape and market trends information on the cardiac markers market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within cardiac markers market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthcare, Alere and Beckman Coulter.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the cardiac markers market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the cardiac markers market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiac markers market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Cardiovascular Disease Overview 8
3.1 Pathophysiology 8
3.2 Disease Burden 9
3.3 Diagnosis 10
4 Cardiac Markers: Market Characterization 11
4.1 Cardiac Markers Market, Global, Revenue ($m), Historic, 2003-2010 11
4.2 Cardiac Markers Market, Global, Revenue ($m), Forecast, 2010-2017 12
4.3 Cardiac Markers, Key Trends 13
4.3.1 Lab-on--a Chip Cardiac Sensor System 13
4.3.2 Use of Predictive Markers for Personalized Treatment 13
4.3.3 High-Sensitivity CRP (hs-CRP) 14
4.3.4 Heart-Type Fatty Acid Binding Protein (H-FABP) 14
4.3.5 Cardiac Biomarker Soluble ST2 (sST2) Exhibits Significant Clinical Value 15
4.3.6 Myeloperoxidase (MPO) 15
4.3.7 Brain Natriuretic Peptide (BNP) 15
4.4 Cardiac Markers, Market Dynamics 16
4.4.1 Cardiac Markers, Market Drivers 16
4.4.2 Cardiac Markers Market Restraints 18
5 Global Cardiac Markers Market, by Country, Revenue ($m), 2003-2017 19
5.1 Cardiac Markers Market, the US, Revenue ($m), Historic, 2003 – 2010 19
5.2 Cardiac Markers Market, the US, Revenue ($m), Forecast, 2010 – 2017 20
5.3 Cardiac Markers Market, Canada, Revenue ($m), Historic, 2003 – 2010 21
5.4 Cardiac Markers Market, Canada, Revenue ($m), Forecast, 2010 – 2017 22
5.5 Cardiac Markers Market, the UK, Revenue ($m), Historic, 2003 – 2010 23
5.6 Cardiac Markers Market, the UK, Revenue ($m), Forecast, 2010 – 2017 24
5.7 Cardiac Markers Market, Germany, Revenue ($m), Historic, 2003 – 2010 25
5.8 Cardiac Markers Market, Germany, Revenue ($m), Forecast, 2010 – 2017 26
5.9 Cardiac Markers Market, France, Revenue ($m), Historic, 2003 – 2010 27
5.10 Cardiac Markers Market, France, Revenue ($m), Forecast, 2010 – 2017 28
5.11 Cardiac Markers Market, Italy, Revenue ($m), Historic, 2003 – 2010 29
5.12 Cardiac Markers Market, Italy, Revenue ($m), Forecast, 2010 – 2017 30
5.13 Cardiac Markers Market, Spain, Revenue ($m), Historic, 2003 – 2010 31
5.14 Cardiac Markers Market, Spain, Revenue ($m), Forecast, 2010 – 2017 32
5.15 Cardiac Markers Market, Japan, Revenue ($m), Historic, 2003 – 2010 33
5.16 Cardiac Markers Market, Japan, Revenue ($m), Forecast, 2010 – 2017 34
5.17 Cardiac Markers Market, China, Revenue ($m), Historic, 2003 – 2010 35
5.18 Cardiac Markers Market, China, Revenue ($m), Forecast, 2010 – 2017 36
5.19 Cardiac Markers Market, India, Revenue ($m), Historic, 2003 – 2010 37
5.20 Cardiac Markers Market, India, Revenue ($m), Forecast, 2010 – 2017 38
5.21 Cardiac Markers Market, Australia, Revenue ($m), Historic, 2003 – 2010 39
5.22 Cardiac Markers Market, Australia, Revenue ($m), Forecast, 2010 – 2017 40
5.23 Cardiac Markers Market, Brazil, Revenue ($m), Historic, 2003-2010 41
5.24 Cardiac Markers Market, Brazil, Revenue ($m), Forecast, 2010 – 2017 42
6 Cardiac Markers Market: Strategic Competitive Assessment 43
6.1 Cardiac Markers Market, Global, Company Share (%), 2010 43
6.2 Cardiac Markers Market, Competitive Analysis 44
6.2.1 Threat of Rivalry 44
6.2.2 Threat of New Entrants 45
6.2.3 Buyer Power 45
6.2.4 Threat of Substitute 45
6.2.5 Supplier Power 45
6.3 Cardiac Markers: Key Market Participants 46
6.3.1 F. Hoffmann-La Roche Ltd. 46
6.3.2 Abbott Laboratories 48
6.3.3 Siemens Healthcare 50
6.3.4 Alere 53
6.3.5 Beckman Coulter, Inc. 55
7 Key Marketed Cardiac Markers 58
7.1 TROP T Sensitive Rapid Assay 58
7.1.1 Product Description 58
7.1.2 Features and Benefits 58
7.2 Cobas c 111 Analyzer 58
7.2.1 Product Description 58
7.2.2 Features and Benefits 58
7.3 I-STAT System 59
7.3.1 Product Description 59
7.3.2 Features and Benefits 59
7.4 Stratus CS Analyzer 59
7.4.1 Product Description 59
7.4.2 Features and Benefits 59
7.5 TriageBNP 60
7.5.1 Product Description 60
7.5.2 Features and Benefits 60
8 Cardiac Markers Market: Strategic Pipeline Assessment 61
8.1 Device Pipeline Products Summary 61
8.2 Profiles of Promising Products Under Clinical Development 65
8.2.1 VASCLIR 65
8.2.2 ARCHITECT MPO ASSAY 66
8.2.3 CADPrint 67
8.2.4 Presage ST2 Assay 68
8.2.5 Verigene Cardiac Troponin I Assay 69
8.2.6 Lab-on-a -Film Cardiac Sensor System 71
9 Cardiac Marker Market: Strategic Deals Analysis 72
9.1 Key Acquisitions 72
9.1.1 Danaher to Acquire Beckman Coulter 72
9.1.2 bioMerieux Completed the Acquisition of Meikang Biotech (Shanghai) 72
9.1.3 Inverness Medical Innovations Acquired 78.13% Stake in Standard Diagnostics 73
9.1.4 VaxGen Completed Acquisition of diaDexus 73
9.1.5 Siemens Medical Solutions Acquired Dade Behring 73
9.2 Key Partnerships 74
9.2.1 BG Medicine Enters Into an Agreement with Siemens Healthcare Diagnostics 74
9.2.2 Axis-Shield Signs Option Agreement with Bio-Rad Laboratories 74
10 Appendix 75
10.1 Definitions 76
10.1.1 Cardiac Markers 76
10.2 Acronyms 76
10.3 Sources 77
10.4 Research Methodology 77
10.5 Secondary Research 77
10.6 Primary Research 78
10.7 Models 78
10.8 Forecasts 78
10.9 Expert Panels 79
10.10 GlobalData Consulting 79
10.11 Contact Us 79
10.12 Disclaimer 79
1.1 List of Tables
Table 1: Cardiac Markers Market, Global, Revenue ($m), 2003-2010 11
Table 2: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017 12
Table 3: Pipeline hs-CRP Cardiac Markers 14
Table 4: Pipeline MPO Cardiac Markers 15
Table 5: Commercial POC Testing for Cardiac Markers 17
Table 6: Cardiac Markers Market, the US, Revenue ($m), 2003-2010 19
Table 7: Cardiac Markers Market, the US, Revenue ($m), 2010-2017 20
Table 8: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010 21
Table 9: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017 22
Table 10: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010 23
Table 11: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017 24
Table 12: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010 25
Table 13: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017 26
Table 14: Cardiac Markers Market, France, Revenue ($m), 2003-2010 27
Table 15: Cardiac Markers Market, France, Revenue ($m), 2010-2017 28
Table 16: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010 29
Table 17: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017 30
Table 18: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010 31
Table 19: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017 32
Table 20: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010 33
Table 21: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017 34
Table 22: Cardiac Markers Market, China, Revenue ($m), 2003-2010 35
Table 23: Cardiac Markers Market, China, Revenue ($m), 2010-2017 36
Table 24: Cardiac Markers Market, India, Revenue ($m), 2003-2010 37
Table 25: Cardiac Markers Market, India, Revenue ($m), 2010-2017 38
Table 26: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010 39
Table 27: Cardiac Markers Market, Australia, Revenue ($m) , 2010-2017 40
Table 28: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010 41
Table 29: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017 42
Table 30: Cardiac Markers Market, Global, Key Company Revenue ($m), 2010 43
Table 31: F. Hoffman-La-Roche, Marketed Products, 2010 46
Table 32: F. Hoffman-La-Roche, Pipeline Products, 2010 46
Table 33: Abbott Laboratories, Marketed Products 48
Table 34: Abbott Laboratories, Pipeline Products 48
Table 35: Siemens Healthcare, Marketed Products, 2010 50
Table 36: Siemens Healthcare, Pipeline Products, 2010 50
Table 37: Beckman Coulter, Inc, Marketed Products 55
Table 38: Beckman Coulter Inc, Pipeline Products, 2010 56
Table 39: TROP T Sensitive Rapid Assay, Features and Benefits 58
Table 40: Cobas c 111 Analyzer, Features and Benefits 58
Table 41: i-STAT System, Features and Benefits 59
Table 42: Stratus CS Analyzer, Features and Benefits 59
Table 43: TriageBNP, Features and Benefits 60
Table 44: Cardiac Markers Market, Global, Pipeline Products 61
Table 45: Cardiac Markers Market, List of Pipeline Products in Clinical Development 62
Table 46: Cardiac Markers Market, List of Pipeline Products in Early Development 63
Table 47: Cardiac Markers Market, List of Pipeline Products 64
Table 48: VASCLIR, Product Status, 2010 65
Table 49: VASCLIR, Clinical Trials, 2010 65
Table 50: ARCHITECT MPO ASSAY, Product Status, 2010 66
Table 51: Architect MPO Assay, Clinical Trials, 2010 66
Table 52: CADPrint, Product Status, 2010 67
Table 53: CADPrint, Clinical Trials, 2010 67
Table 54: PresageAssay ST2, Product Status, 2010 68
Table 55: PresageAssay ST2, Clinical Trial, 2010 68
Table 56: Verigene Cardiac Troponin I Assay, Product Status, 2010 69
Table 57:Verigene Cardiac Troponin I Assay, Clinical Trial, 2010 69
Table 58:Lab-on-a Film Cardiac Sensor System, Product Status 71
1.2 List of Figures
Figure 1: Cardiovascular Diseases, Pathphysiology 8
Figure 2: Cardiovascular Disease Burden, Global, 2010 9
Figure 3: Cardiac Markers Market, Global, Revenue ($m), 2003-2010 11
Figure 4: Cardiac Markers Market, Global, Revenue ($m), 2010- 2017 12
Figure 5: Diagnostic Work Flow Diagram for Underlying Personalized Medicine 13
Figure 6: Cardiac Markers Market, Global, Market Dynamics 16
Figure 7: Cardiac Markers Market, the US, Revenue ($m), 2003-2010 19
Figure 8: Cardiac Markers Market, the US, Revenue ($m), 2010-2017 20
Figure 9: Cardiac Markers Market, Canada, Revenue ($m), 2003-2010 21
Figure 10: Cardiac Markers Market, Canada, Revenue ($m), 2010-2017 22
Figure 11: Cardiac Markers Market, the UK, Revenue ($m), 2003-2010 23
Figure 12: Cardiac Markers Market, the UK, Revenue ($m), 2010-2017 24
Figure 13: Cardiac Markers Market, Germany, Revenue ($m), 2003-2010 25
Figure 14: Cardiac Markers Market, Germany, Revenue ($m), 2010-2017 26
Figure 15: Cardiac Markers Market, France, Revenue ($m), 2003-2010 27
Figure 16: Cardiac Markers Market, France, Revenue ($m), 2010-2017 28
Figure 17: Cardiac Markers Market, Italy, Revenue ($m), 2003-2010 29
Figure 18: Cardiac Markers Market, Italy, Revenue ($m), 2010-2017 30
Figure 19: Cardiac Markers Market, Spain, Revenue ($m), 2003-2010 31
Figure 20: Cardiac Markers Market, Spain, Revenue ($m), 2010-2017 32
Figure 21: Cardiac Markers Market, Japan, Revenue ($m), 2003-2010 33
Figure 22: Cardiac Markers Market, Japan, Revenue ($m), 2010-2017 34
Figure 23: Cardiac Markers Market, China, Revenue ($m), 2003-2010 35
Figure 24: Cardiac Markers Market, China, Revenue ($m), 2010-2017 36
Figure 25: Cardiac Markers Market, India, Revenue ($m), 2003-2010 37
Figure 26: Cardiac Markers Market, India, Revenue ($m), 2010-2017 38
Figure 27: Cardiac Markers Market, Australia, Revenue ($m), 2003-2010 39
Figure 28: Cardiac Markers Market, Australia, Revenue ($m), 2010-2017 40
Figure 29: Cardiac Markers Market, Brazil, Revenue ($m), 2003-2010 41
Figure 30: Cardiac Markers Market, Brazil, Revenue ($m), 2010-2017 42
Figure 31: Cardiac Markers Market, Global, Key Company Share, 2010 43
Figure 32: Cardiac Markers Market, Competitive Analysis 44
Figure 33: F. Hoffman-La-Roche, SWOT Analysis 47
Figure 34: Abbott, SWOT Analysis 49
Figure 35: Siemens, SWOT Analysis 51
Figure 36: Alere, SWOT Analysis 54
Figure 37: Beckman Coulter, SWOT Analysis 56
Figure 38: Cardiac Markers Market, Global, Pipeline Products 61F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Siemens Healthcare
Alere
Beckman Coulter, Inc.
To order this report:
: Cardiac Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecast to 2017
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article